Header graphic for print
Biosimilars Law Blog
Posted in News & Events

Breaking decisions from the Supreme Court: Term in review

On Tuesday afternoon, three of Hogan Lovells’ Appellate practice partners will provide an analysis of some of the key decisions that will impact businesses as the Supreme Court concludes its current term.

Neal Katyal, former Acting Solicitor General of the United States and Appellate practice Co-Director, Cate Stetson, Co-Director of our Appellate practice; and Chris Handman, a seasoned Appellate partner, will conduct a 30-minute webcast on the ramifications of decisions handed down by the high court this term, which may include the Affordable Care Act, and how the three key cases challenging aspects of President Obama’s healthcare plan will be resolved.  As previously posted, the outcome of the decisions on the Affordable Care Act could have direct implications for the U. S. biosimilars pathway.

The half-hour program, which begins at 1 p.m. on June 26, will also provide essential background on the Supreme Court, including the composition, recent personnel changes, and background on the Justices, and explain the impact of these structures on the decisions.

Register online for the free webcast.